表观遗传调控基因可区分颅内与颅外黑色素瘤转移灶
本研究对配对黑色素瘤转移灶进行甲基化组与转录组整合组学分析,鉴定出38个候选基因在颅内与颅外转移灶间启动子甲基化及表达存在差异;11个最有前景的基因经免疫组化在肿瘤及周围正常组织中验证,其中STK10、PDXK、WDR24、CSSP1、NMB、RASL11B、磷酸化PRKCZ、PRKCZ和磷酸化GRB10在颅内转移灶中蛋白表达显著不同。变化提示颅内表型伴蛋白激酶B磷酸化增加及增殖细胞比例升高;敲低PRKCZ或GRB10改变磷酸化蛋白激酶B表达并降低脑特异性黑色素瘤细胞系活力。
要点
- 38个候选基因在颅内与颅外转移灶间启动子甲基化及表达存在差异。
- 9种蛋白在颅内转移灶中表达显著不同,包括STK10、PDXK、WDR24等。
- 颅内转移灶表现为蛋白激酶B磷酸化增加及增殖细胞比例升高。
核心结论
- 表观遗传调控的肿瘤相关改变可区分脑转移与其他器官转移,并可能通过靶向受累信号通路加以利用。
研究设计与样本
- 研究对一组配对黑色素瘤转移灶的甲基化组与转录组进行整合组学数据分析,并在肿瘤及周围正常组织中以免疫组化验证蛋白表达。
主要发现
- 鉴定出38个候选基因在颅内与颅外转移灶间显示不同的启动子甲基化和相应基因表达变化。
- 11个最有前景的基因在蛋白水平验证,STK10、PDXK、WDR24、CSSP1、NMB、RASL11B、磷酸化PRKCZ、PRKCZ和磷酸化GRB10在颅内转移灶中蛋白表达显著不同。
- 观察到的变化提示颅内表型伴蛋白激酶B磷酸化增加和增殖细胞比例升高。
- 敲低PRKCZ或GRB10改变磷酸化蛋白激酶B表达并降低脑特异性黑色素瘤细胞系活力。
关键数值与推荐
- 38个候选基因显示颅内与颅外转移灶间启动子甲基化及相应基因表达差异。
- 11个基因在蛋白水平验证,其中9种蛋白(STK10、PDXK、WDR24、CSSP1、NMB、RASL11B、磷酸化PRKCZ、PRKCZ、磷酸化GRB10)在颅内转移灶中表达显著不同。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite remarkable advances in treating patients with metastatic melanoma, the management of melanoma brain metastases remains challenging. Recent evidence suggests that epigenetic reprogramming is an important mechanism for the adaptation of melanoma cells to the brain environment. In this study, the methylomes and transcriptomes of a cohort of matched melanoma metastases were evaluated by integrated omics data analysis. The identified 38 candidate genes displayed distinct promoter methylation and corresponding gene expression changes in intracranial compared with extracranial metastases. The 11 most promising genes were validated on protein level in both tumor and surrounding normal tissue using immunohistochemistry. In accordance with the underlying promoter methylation and gene expression changes, a significantly different protein expression was confirmed for STK10, PDXK, WDR24, CSSP1, NMB, RASL11B, phosphorylated PRKCZ, PRKCZ, and phosphorylated GRB10 in the intracranial metastases. The observed changes imply a distinct intracranial phenotype with increased protein kinase B phosphorylation and a higher frequency of proliferating cells. Knockdown of PRKCZ or GRB10 altered the expression of phosphorylated protein kinase B and decreased the viability of a brain-specific melanoma cell line. In summary, epigenetically regulated cancer-relevant alterations were identified that provide insights into the molecular mechanisms that discriminate brain metastases from other organ metastases, which could be exploited by targeting the affected signaling pathways.
引用
- Westphal D, Meinhardt M, Grützmann K, et al. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases. J Invest Dermatol. 2023. PMID: 36716920. doi:10.1016/j.jid.2023.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。